Concepedia

Karen A. Maegley

KA

Statistics

Publications

32

Citations

2.9K

H-Index

25

Active since

1991

Affiliations

Pfizer (United States)(Current)

Newcastle University

Bone Therapeutics

Griffith University

Commonwealth Scientific and Industrial Research Organisation

Karen A. Maegley is an author at Pfizer (United States) specializing in medicine, drug discovery, and natural sciences.

Top concepts

Publications per year

1991–2023

32

Publications

32

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 482 citations · Full text

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Huw D. Thomas, Christopher Calabrese, Michael A. Batey et al. · Molecular Cancer Therapeutics · 2007 · 297 citations

Resistance-Modifying Agents. 9. Synthesis and Biological Properties of Benzimidazole Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase

Alex W. White, Robert J. Almassy, A. Hilary Calvert et al. · Journal of Medicinal Chemistry · 2000 · 285 citations · Full text

Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance

Alexei Brooun, K.S. Gajiwala, Ya‐Li Deng et al. · Nature Communications · 2016 · 158 citations · Full text

Tricyclic Benzimidazoles as Potent Poly(ADP-ribose) Polymerase-1 Inhibitors

Donald J. Skalitzky, Joseph Marakovits, Karen A. Maegley et al. · Journal of Medicinal Chemistry · 2002 · 152 citations · Full text

, , +13

1–5 of 32